BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29642484)

  • 1. Differential Expression and Clinical Significance of Transforming Growth Factor-Beta Isoforms in GBM Tumors.
    Roy LO; Poirier MB; Fortin D
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-β pathway activity in glioblastoma.
    Frei K; Gramatzki D; Tritschler I; Schroeder JJ; Espinoza L; Rushing EJ; Weller M
    Oncotarget; 2015 Mar; 6(8):5963-77. PubMed ID: 25849941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.
    Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L
    Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
    Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
    Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
    Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
    J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-β and stem cell markers are highly expressed around necrotic areas in glioblastoma.
    Iwadate Y; Matsutani T; Hirono S; Shinozaki N; Saeki N
    J Neurooncol; 2016 Aug; 129(1):101-7. PubMed ID: 27193555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway.
    Chen CW; Yang CH; Lin YH; Hou YC; Cheng TJ; Chang ST; Huang YH; Chung ST; Chio CC; Shan YS; Cheng HC; Chang WT
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression.
    Nana AW; Yang PM; Lin HY
    Asian Pac J Cancer Prev; 2015; 16(16):6813-23. PubMed ID: 26514451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway.
    Silginer M; Burghardt I; Gramatzki D; Bunse L; Leske H; Rushing EJ; Hao N; Platten M; Weller M; Roth P
    Oncogene; 2016 Jun; 35(25):3260-71. PubMed ID: 26500056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma.
    Kim BS; Kong DS; Seol HJ; Nam DH; Lee JI
    J Neurooncol; 2017 Jul; 133(3):615-622. PubMed ID: 28536992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Ki-67 index overexpression in IDH wild type glioblastoma a predictor of shorter Progression Free survival? A clinical and Molecular analytic investigation.
    Armocida D; Frati A; Salvati M; Santoro A; Pesce A
    Clin Neurol Neurosurg; 2020 Nov; 198():106126. PubMed ID: 32861131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance of fascin expression in a newly diagnosed primary glioblastoma.
    Park KS; Lee HW; Park SH; Park TI; Hwang JH
    J Neurooncol; 2016 Sep; 129(3):495-503. PubMed ID: 27406586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.
    Michaelsen SR; Urup T; Olsen LR; Broholm H; Lassen U; Poulsen HS
    J Neurooncol; 2018 May; 137(3):533-542. PubMed ID: 29305787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.
    Lämmer F; Delbridge C; Würstle S; Neff F; Meyer B; Schlegel J; Kessel KA; Schmid TE; Schilling D; Combs SE
    PLoS One; 2019; 14(8):e0221502. PubMed ID: 31430337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
    PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone.
    Jungk C; Mock A; Exner J; Geisenberger C; Warta R; Capper D; Abdollahi A; Friauf S; Lahrmann B; Grabe N; Beckhove P; von Deimling A; Unterberg A; Herold-Mende C
    BMC Med; 2016 Oct; 14(1):170. PubMed ID: 27782828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSP47 Promotes Glioblastoma Stemlike Cell Survival by Modulating Tumor Microenvironment Extracellular Matrix through TGF-β Pathway.
    Jiang X; Zhou T; Wang Z; Qi B; Xia H
    ACS Chem Neurosci; 2017 Jan; 8(1):128-134. PubMed ID: 27696866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.